Cargando…
Abstract 56: A Patient Specific Tissue Engineered Biomimetic Platform For High Throughput Analysis Of Breast Cancer Therapeutic Options
Autores principales: | Toyoda, Yoshiko, Celie, Karel-Bart, Buro, Justin, Lin, Alexandra, Xu, Jonathan, Abadeer, Andrew, Jin, Julia, Morgan, John, Brown, Kristy A., Spector, Jason A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959672/ http://dx.doi.org/10.1097/01.GOX.0000533921.19808.98 |
Ejemplares similares
-
Abstract: Plug ‘n Play: Induction of Biomimetic and Hierarchical Angiogenesis Under Stimulation with S1P
por: Scott Buro, Justin, et al.
Publicado: (2018) -
Abstract 138: Interrogating the Metabolic Interactions Between Adipocytes and Breast Cancer in a Patient-Derived Tissue Engineered Platform--Implications for the Safety of Autologous Fat Transfer in the Setting of Breast Ductal Carcinoma
por: Toyoda, Yoshiko, et al.
Publicado: (2018) -
Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform
por: Lara, Daniel, et al.
Publicado: (2019) -
Abstract QS31: Micropatterned Microsphere Scaffolds: Optimizing the Performance of Engineered Dermal Substitutes
por: Celie, Karel-Bart, et al.
Publicado: (2018) -
Abstract QS36: A Vascularized, Three-dimensional Biomimetic Platform for Patient-Specific, ex-vivo studies of Breast Cancer Invasion and Metastasis
por: Lara, Daniel, et al.
Publicado: (2019)